Kiora Pharmaceuticals Inc (KPRX) Stock Analysis

Kiora Pharmaceuticals Inc (KPRX) is a publicly traded company in the HEALTHCARE sector. It trades at $2.72, carries a market capitalization of $12.12M. This page summarizes the public market data, fundamentals, and frequently asked questions for KPRX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.72
• Market Cap: $12.12M
• EPS: $-2.70
• 52-Week High: $3.78
• 52-Week Low: $1.76

Market Sentiment

Kiora Pharmaceuticals Inc currently has a Neutral sentiment score of -0.04.

About Kiora Pharmaceuticals Inc

None

GNG Research Analysis

GNG Research scores Kiora Pharmaceuticals Inc (KPRX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for KPRX.

Frequently Asked Questions

Does KPRX pay dividends?

Kiora Pharmaceuticals Inc (KPRX) does not currently pay a regular dividend.

What is KPRX's market cap?

Kiora Pharmaceuticals Inc (KPRX) has a market capitalization of $12.12M with a current stock price of $2.72.